WASHINGTON — What is the biggest difference in working at the Food and Drug Administration under its new commissioner, Scott Gottlieb?

“Well, he’s making an announcement every day,” Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research, said at a STAT Plus subscriber event on Monday. “We have to scurry around and make sure we’re all lined up against all his announcements. ”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy